Literature DB >> 11229717

Transit dose of an Ir-192 high dose rate brachytherapy stepping source.

T P Wong1, W Fernando, P N Johnston, I F Bubb.   

Abstract

Clinical dosimetry for high dose rate (HDR) brachytherapy with a single stepping source generally neglects the transit dose. This study investigates the effects of the transit dose in the target volume of an HDR brachytherapy stepping source. A video method was used to analyse the entrance, exit and the interdwell transit speed of the source for different path lengths and step sizes ranging from 2.5 mm to 995 mm. The transit speed was found to vary with the step size and path length. For the travelled distances of 2.5, 5.0, 10.0, 230 and 995 mm, the average transit speeds were 54, 72, 233, 385 and 467 mm s(-1) respectively. The results also show that the manufacturer has attempted to compensate for the effects of interdwell transit dose by reducing the actual dwell time of the source. A well-type chamber was used to determine the dose differences between two sets of measurements, one being the stationary dose only and the other being the sum of stationary and transit doses. Single catheters of active lengths of 20 and 40 mm, different dwell times of 0.5, 1, 2 and 5 s and different step sizes of 2.5, 5 and 10 mm were used in the measurements with the well-type chamber. Most of the measured dose differences between stationary and stationary plus interdwell source movement were within 2%. The additional dose due to the source transit can be as high as 24.9% for the case of 0.5 s dwell time, 10 mm step size and 20 mm active length. The dose difference is mainly due to the entrance and exit source movement but not the interdwell movement.

Mesh:

Substances:

Year:  2001        PMID: 11229717     DOI: 10.1088/0031-9155/46/2/304

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  5 in total

1.  Monte Carlo dose calculation of GZP6 (60)Co stepping source based on a matrix shift technique.

Authors:  Mohammad Taghi Bahreyni Toossi; Malihe Abdollahi; Mahdi Ghorbani
Journal:  Rep Pract Oncol Radiother       Date:  2010-12-21

2.  A Monte Carlo study on dose distribution validation of GZP6 (60)Co stepping source.

Authors:  Mohammad Taghi Bahreyni Toossi; Maliheh Abdollahi; Mahdi Ghorbani
Journal:  Rep Pract Oncol Radiother       Date:  2012-11-21

3.  An audit of high dose-rate prostate brachytherapy treatment planning at six Swedish clinics.

Authors:  Frida Dohlmar; Sakarias Johansson; Torbjörn Larsson; Michael Sandborg; Åsa Carlsson Tedgren
Journal:  J Contemp Brachytherapy       Date:  2021-02-18

4.  In Vivo Verification of Treatment Source Dwell Times in Brachytherapy of Postoperative Endometrial Carcinoma: A Feasibility Study.

Authors:  Antonio Herreros; José Pérez-Calatayud; Facundo Ballester; Jose Barrera-Gómez; Rosa Abellana; Joana Melo; Luis Moutinho; Luca Tagliaferri; Ángeles Rovirosa
Journal:  J Pers Med       Date:  2022-05-31

Review 5.  Review of clinical brachytherapy uncertainties: analysis guidelines of GEC-ESTRO and the AAPM.

Authors:  Christian Kirisits; Mark J Rivard; Dimos Baltas; Facundo Ballester; Marisol De Brabandere; Rob van der Laarse; Yury Niatsetski; Panagiotis Papagiannis; Taran Paulsen Hellebust; Jose Perez-Calatayud; Kari Tanderup; Jack L M Venselaar; Frank-André Siebert
Journal:  Radiother Oncol       Date:  2013-11-30       Impact factor: 6.280

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.